Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Less opioids after major abdominal surgery in young infants using wound catheter infusion with local anesthetics
2015-002209-12Phase 3Terminated
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain and Ileal atresia (2 arms), sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Mean cumulative morphine dose over 48 hours. Started Apr 2017; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative painIleal atresia
Beyond the preview
Go deeper on 2015-002209-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002209-12.